Mahathir Bayena

Macro Metals (ASX:M4M) completed its acquisition of the Yandi South Iron Ore Project on Oct. 14 for a consideration payment of $1 million.

Bo Hines, a former White House crypto adviser, co-owned Nxum while it secured a $6.3 million Tether deal, according to an exclusive report by The Wall Street Journal.

Dusk Group (ASX:DSK) lifted like-for-like sales by 7.2% in the first 15 weeks of FY27, backed by strong store productivity and improved stock availability.

Maggie Beer Holdings (ASX:MBH) ended the strategic review of its subsidiary Hampers and Gifts Australia and decided against selling the business.

Mayne Pharma (ASX:MYX) has settled its US patent litigation with Teva Pharmaceuticals USA over generic versions of the menopause treatment IMVEXXY.

Tron Inc (NASDAQ:TRON) has filed to raise up to $200 million through an at-the-market equity offering to fund additional TRON (TRX) purchases.

Australian Ethical Investment (ASX:AEF) reported funds under management of $14.43 billion for the quarter ended Sept. 30.

Austco Healthcare (ASX:AHC) has entered into a binding share purchase agreement to acquire 100% of Brisbane-based software business RTM Hold for an estimated total consideration of $15.3 million.

Aquestive Therapeutics (NASDAQ:AQST) received FDA acceptance for its Anaphylm resubmission with a March 16, 2027 action date.

The Charles Schwab Corporation (NYSE:SCHW) reported third-quarter 2026 adjusted earnings per share of $1.69 to top analyst projections.